PPBT

1.5250.33%
SN

Suzana Nahum-Zilberberg

Independent Director

Ms. Suzana Nahum-Zilberberg was Independent Vice Chairman of the Board of BioLight Life Sciences Ltd. from July 01, 2020 to May 2025. Ms. Nahum-Zilberberg was Chief Executive Officer of BioLight Life Sciences Ltd. until May 2020. She was an External Director of Matricelf Ltd from September 04, 2022 to 2025. She is Independent Director of Purple Biotech Ltd from May 2021. She also serves as a director at Human Xtention Ltd. and Nextferm Technologies Ltd. Mrs. Nahum-Zilberberg served as the Chief Executive Officer at BioLight Life Sciences Ltd. since May 2011. Previously, she worked at Teva Pharmaceuticals Industries Ltd in several positions, as Vice President Asia and Pacific, led the penetration of Teva into Japan and China. In her position She led the JV agreement with Kowa Pharmaceutical in 2008 and the acquisition of Taisho Pharmaceutical in 2009, led Teva to become the fifth largest generic company in Japan. She serves as Vice Chairman of Nextage Therapeutics Ltd (formerly known as Micromedic Technologies Ltd). She serves as a Director of IOPtima Ltd., Nextage Therapeutics Ltd (formerly known as Micromedic Technologies Ltd). and Zetiq Technologies Ltd. Mrs. Nahum-Zilberberg holds a BA in Accounting & Economics from Tel Aviv University and MBA in Finance & Marketing from Tel Aviv University. She is certified Certified Public Accountant.

Positions